| Similar Articles |
|---|
 |
BusinessWeek
March 31, 2011
Peter Waldman |
Aetna's Rx for High Doctor Fees: Lawsuits Aetna's legal campaign against expensive out-of-network charges is just the latest attempt by insurers to restrain soaring health costs.   |
Entrepreneur
November 2005
Don Debelak |
Doctor's Orders Getting the FDA to give your medical invention the thumbs up can be a challenge. Entrepreneurs, follow this prescription for approval. |
Managed Care
June 2007
Frank Diamond |
Gum Control: Should the Medical Benefit Cover Some Dental Services? Knowledge that oral health may affect overall health is prompting some plans to act. |
Insurance & Technology
October 29, 2003
Anthony O'Donnell |
Aetna Offers Solution to Suit The carrier's settlement with the American Dental Association aims at communications clarity. |
The Motley Fool
June 27, 2011
Arundhati Parmar |
St. Jude Medical's Migraine Treatment: Good for Europe, but Not the U.S.? St. Jude won't comment on whether the company plans to do a second clinical trial or whether it is confident it will win approval from the FDA without it. |
The Motley Fool
September 24, 2008
Brian Orelli |
Health Insurer Lets Outsiders Decide Aetna announces that it'll allow customers with individual health plans to ask for an independent external review before Aetna cancels their policy. |
BusinessWeek
October 22, 2009
Arlene Weintraub |
Tough Love, Lower Health Costs A UnitedHealthcare plan offers incentives to employees who strictly control their diabetes. |
IndustryWeek
October 19, 2011 |
FDA: A Future Innovation Partner? Could the Food and Drug Administration reform itself to help manufacturers create new medical technologies? |
Pharmaceutical Executive
October 1, 2006
Jill Wechsler |
Washington Report: After Plan B: Out of the Quagmire, into the Data The morning-after pill goes OTC, with some special requirements. But is FDA's drug information system up to the task of tracking how it is used? |
The Motley Fool
May 16, 2005
Tom Taulli |
Aetna Gets Active Aetna's purchase of ActiveHealth should help the company continue its cost-containment measures. |
Pharmaceutical Executive
August 1, 2012
Jill Wechsler |
Fleshing Out FDASIA Medical apps, e-submissions, counterfeit drugs, and imports tucked into fairly "clean" user-fee renewal legislation. In late June leading legislators reached across party lines to quickly approve the Food and Drug Administration Safety and Innovation Act. |
Insurance & Technology
September 16, 2005
Katherine Burger |
Educating Consumers A truly technology-enabled offering, the idea behind consumer-directed healthcare is that everyone benefits when consumers have more information. |
Pharmaceutical Executive
November 1, 2011
Jill Wechsler |
The Drug Shortages Struggle Clamor for critical therapies prompts probes of prices, production practices. |
The Motley Fool
February 16, 2010
Brian Orelli |
For Blockbuster Cancer Drugs, Approvals Are the Easy Part Don't get too excited. As an investor, you can lower your risk by investing in cancer drug companies after a clinical trial success but before an FDA approval, but you'll also reduce your reward. |
BusinessWeek
March 1, 2004
Kate Murphy |
Brushing Your Teeth Away Too much zeal -- and the wrong toothbrush -- are creating a new set of problems |
Popular Mechanics
November 28, 2007 |
Dental Tech Coming Soon to a Mouth Near You You'll be happy these oral solutions are right around the corner -- digital dental imagery and reduced-risk root canal. |
Pharmaceutical Executive
August 1, 2014
Jill Wechsler |
Social Media Struggles Continue Tweeting limited, corrections okay, says FDA, as industry, regulators wrestle with the digital world. |
Pharmaceutical Executive
December 1, 2013 |
FDA Pursues Delicate Balancing Act The Agency struggles to ensure access to needed medicines while minimizing potential risks, writes Jill Wechsler. |
Pharmaceutical Executive
September 1, 2010 |
The Testing of the Tests FDA seeks to regulate genetic tests more actively, while encouraging diagnostic development. |
